Russell Investments Group
IRWD icon

Russell Investments Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Russell Investments Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$915K Sell
261,789
-3,568
-1% -$14.6K ﹤0.01% 2264
2025
Q4 		$894K Sell
265,357
-61,210
-19% -$159K ﹤0.01% 2270
2025
Q3 		$429K Buy
326,567
+117,706
+56% +$122K ﹤0.01% 2534
2025
Q2 		$150K Sell
208,861
-9,167
-4% -$7.2K ﹤0.01% 2720
2025
Q1 		$320K Sell
218,028
-202,423
-48% -$482K ﹤0.01% 2458
2024
Q4 		$1.86M Sell
420,451
-42,596
-9% -$173K ﹤0.01% 1703
2024
Q3 		$1.91M Sell
463,047
-91,648
-17% -$493K ﹤0.01% 1705
2024
Q2 		$3.62M Sell
554,695
-223,152
-29% -$1.58M 0.01% 1311
2024
Q1 		$6.78M Buy
777,847
+552,227
+245% +$6.7M 0.01% 1025
2023
Q4 		$2.58M Buy
225,620
+64,378
+40% +$637K ﹤0.01% 1480
2023
Q3 		$1.55M Buy
161,242
+72,610
+82% +$712K ﹤0.01% 1693
2023
Q2 		$943K Buy
88,632
+67,870
+327% +$729K ﹤0.01% 1964
2023
Q1 		$218K Sell
20,762
-16,610
-44% -$186K ﹤0.01% 2462
2022
Q4 		$463K Buy
37,372
+29,818
+395% +$338K ﹤0.01% 2318
2022
Q3 		$77K Hold
7,554
– – ﹤0.01% 2704
2022
Q2 		$87K Sell
7,554
-10,391
-58% -$122K ﹤0.01% 2678
2022
Q1 		$225K Sell
17,945
-10,619
-37% -$122K ﹤0.01% 2436
2021
Q4 		$332K Sell
28,564
-106,941
-79% -$1.31M ﹤0.01% 2571
2021
Q3 		$1.77M Sell
135,505
-19,612
-13% -$253K ﹤0.01% 1902
2021
Q2 		$1.99M Sell
155,117
-168,740
-52% -$1.93M ﹤0.01% 1923
2021
Q1 		$3.62M Buy
323,857
+249,093
+333% +$2.63M 0.01% 1535
2020
Q4 		$850K Sell
74,764
-20,839
-22% -$228K ﹤0.01% 2191
2020
Q3 		$869K Sell
95,603
-49,487
-34% -$492K ﹤0.01% 2138
2020
Q2 		$1.49M Buy
145,090
+106,127
+272% +$1.09M ﹤0.01% 1815
2020
Q1 		$392K Sell
38,963
-171,684
-82% -$2.02M ﹤0.01% 2284
2019
Q4 		$2.8M Buy
210,647
+198,247
+1,599% +$2.19M 0.01% 1539
2019
Q3 		$107K Hold
12,400
– – ﹤0.01% 2818
2019
Q2 		$135K Buy
+12,400
New +$139K ﹤0.01% 2590
2018
Q4 		– Sell
-93,630
Closed -$1.45M – 2975
2018
Q3 		$1.45M Sell
93,630
-9,175
-9% -$145K ﹤0.01% 1921
2018
Q2 		$1.65M Buy
102,805
+7,653
+8% +$113K ﹤0.01% 1864
2018
Q1 		$1.23M Sell
95,152
-29,862
-24% -$372K ﹤0.01% 2107
2017
Q4 		$1.61M Sell
125,014
-45,826
-27% -$599K ﹤0.01% 1932
2017
Q3 		$2.26M Buy
170,840
+49,439
+41% +$680K ﹤0.01% 1716
2017
Q2 		$1.92M Buy
121,401
+89,616
+282% +$1.3M ﹤0.01% 1762
2017
Q1 		$454K Sell
31,785
-2,308
-7% -$31.6K ﹤0.01% 2464
2016
Q4 		$436K Buy
+34,093
New +$431K ﹤0.01% 2518

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Russell Investments Group's IRWD Position: Q1 2026 in Review

Russell Investments Group reduced its Ironwood Pharmaceuticals (IRWD) stake by 1.3% in Q1 2026, selling an estimated $14.6K and leaving 261,789 shares worth $915K. The position accounts for ﹤0.01% of the portfolio, ranked #2264.

Russell Investments Group first reported a position in IRWD in Q4 2016 and has held it in 36 quarters since. The position peaked at $6.78M in Q1 2024. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Russell Investments Group held 261,789 shares of Ironwood Pharmaceuticals worth $915K as of Q1 2026.
  • Russell Investments Group sold 3,568 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $14.6K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #2264 holding.
  • Russell Investments Group first reported a position in Ironwood Pharmaceuticals in Q4 2016 and has held it in 36 quarters since.
  • Russell Investments Group's Ironwood Pharmaceuticals position peaked at $6.78M in Q1 2024.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.